Job title: Senior Scientist, Immunogenicity, Drug Metabolism & Pharmacokinetics Group Lead
Konstantin Piatkov, Group Lead, Immunogenicity, Global DMPK Oncology and Rare Diseases, Takeda Pharmaceuticals, will explain why developing predictive computational approaches is key to success in immunogenicity assessment and mitigation for gene therapy programs.
An Adaptive in Silico Immunogenicity Prediction Platform 11:00 am
De-immunization effort for the mitigation of immunogenicity risk using in silico analysis Emulating immune response in patients using computational tools Integrative approach to improve the predictability of immunogenicity assessmentRead more
day: Day 1 Track A AM